Summary
The Netherlands and Belgium are known major producers of synthetic psychoactive drugs such as MDMA, amphetamine and, more recently, methamphetamine. The present study shows that as a result of the illicit production of these synthetic drugs, large volumes of chemical waste are generated and encountered in the environment after disposal. It is estimated that between 25 and 43 kilograms of (liquid) drug production waste is generated per kilogram of produced drug. Knowledge on the composition and the emission of synthetic drug production waste is limited. However, emissions onto or into soil and surface water pose a particular environmental risk. In a field study that was performed as part of the current project, residues of drug production waste, including the produced MDMA, amphetamine and methamphetamine as well as several known by-products, were encountered in the surface water and sediment of a former, remediated drug production waste dump location. Concentration patterns followed a trend, with the highest concentrations in the sediment and water near the former point of emission and lower concentrations found further away from this location. The current literature review and field study illustrate that knowledge on the occurrence and fate of drug production waste residues in surface waters, soils, sediments and groundwater remains limited, and that field research of dump locations is hampered by restrictions to site accessibility. The current remediation strategies applied by local authorities when drug production waste is encountered may overlook the environmental aspects and risks associated with the emission of such residues.Download as PDF
Environmental impact of synthetic drug production
PDF files are made available as a convenience. In cases where the EMCDDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoritative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.
Additional information
This paper was commissioned by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), to provide background material to inform and contribute to the analysis of EU Drug Markets. This background paper was produced under contract no CT.21.SAS.0107.1.0 and we are grateful for the authors’ valuable contributions. The paper is available online for those who would like further information on the topic. The views, interpretations and conclusions set out are those of the authors and are not necessarily those of the EMCDDA or its partners, any EU Member State or any agency or institution of the European Union.
Organisation (author):
KWR Water Research Institute, Netherlands
Category
Document language
- English
Main subject
Target audience